Answers are grounded in this paper and cite their sources.
Several Delphinium species are used in Tibetan medicine, and their diterpenoid alkaloids (DAs) account for both bioactivity and toxicity, yet where DA biosynthetic genes are expressed remains unclear. We sequenced root, stem, leaf, and flower transcriptomes of three wild plants each of D. gyalanum, a Tibetan medicinal source species, and D. kingianum, collected at full bloom at 4933 m and 4807 m on the Qinghai–Tibet Plateau. Gene-tree placement identified orthologs of all six characterized DA entry-step enzymes in D. gyalanum and of four in D. kingianum. Their expression was highest in roots in 7 of 10 step–species combinations and in stems in the other 3, and low in leaves and flowers. Root-over-leaf expression was more frequent among these orthologs than among other members of the same gene trees (odds ratio: 24.4, 95% CI: 3.5–173), whereas screened homologs did not differ from other P450, terpene synthase, and DA synthase clusters (1.7, 0.7–4.5). In both species, VDE and ZEP were most highly expressed in leaves, leaf-biased clusters were enriched for high-light, antioxidant, and carotenoid functions, and anthocyanin markers peaked in flowers. These results provide candidate genes for functional studies of DA biosynthesis and an organ-level reference for medicinal Delphinium species.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: